Post-BPI

Discussion in 'Teva Oncology' started by anonymous, Apr 28, 2016 at 1:07 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    So, we've gotten our payouts and a few people left right away. Well, they saw that coming, right? Now what? It's almost May and potential generics and Eagle/Spectrum benda. Boy, Eagle is really screwing us on that one, huh? Rumor has it all territories aren't being back filled. The ones that are getting backfilled have almost no applicants because who wants to jump on this sinking ship? And we keep getting promises of an acquisition or co-promote. Who told them this sales force would stick around for a co-promote anyway? No one likes co-promotes. And as we continue to lose people I doubt we'll get that anyway. Time to clean up that resume, folks.
     

  2. anonymous

    anonymous Guest


    Our sales force has got to be the greenest out there. Why would anyone copromote with us? I think our days are numbered. JM isn't the best BD out there, apparently. Either that or Teva is just too cheap to pay for something decent. Sick of getting strung along with BD promises.
     
  3. anonymous

    anonymous Guest

    Hasn't this been the same arguments that have been posted here for years. You complainers are a bunch of pussies. If you don't like it, leave.
     
  4. anonymous

    anonymous Guest

    Go felch!